Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with ... (News-Medical-Net)
Biologic disease-modifying antirheumatic drugs (DMARDs) such as adalimumab, etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA). These drugs act more quickly, require less laboratory monitoring, and are better tolerated than nonbiologic DMARDs, but they are also up to 100 times more expensive.

Options exist for Medicare doughnut hole (Centre Daily Times)
Q: Help! I have gotten into the doughnut hole with my Medicare Part D Prescription

Will Cost of Arthritis Drugs Soon Be More than Medicare, Senior Citizens Can Afford? (Senior Journal)
June 2, 2009 Certain drugs that are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA), a common condition for senior citizens, are so expensive they are putting pressure on Medicare Part D plans and beneficiaries.

Elder Law Seminars hosted by Flushing House (Queens Courier)
Are you a senior citizen stuck on a financial roller coaster due to the Medicare Part D doughnut hole?